Raymond James analyst Andrew Cooper reiterated a Market Perform on Neogenomics (NASDAQ: NEO).The analyst comments "Quick take: This morning NeoGenomics ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE